Major bleeding complicating contemporary primary percutaneous coronary interventions-incidence, predictors, and prognostic implications

Cardiovascular Revascularization Medicine

Volumn 10, Issue 2, 2009, Pages 88-93

  Fuchs, Shmuel ^a   Kornowski, Ran ^a   Teplitsky, Igal ^a   Brosh, David ^a   Lev, Eli ^a   Vaknin Assa, Hana ^a   Ben Dor, Itsik ^a   Iakobishvili, Zaza ^a   Rechavia, Eldad ^a   Battler, Alexander ^a   Assali, Abed ^a  

^a RABIN MEDICAL CENTER   (Israel)

Author keywords

Bleeding; Primary angioplasty; ST Elevation myocardial infarction

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; EPTIFIBATIDE; HEPARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; AORTA BALLOON; ARTICLE; BLEEDING; BLOOD CLOTTING TIME; BLOOD TRANSFUSION; DISEASE SEVERITY; FEMALE; HEART INFARCTION; HUMAN; INCIDENCE; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; SEX DIFFERENCE; ST SEGMENT ELEVATION;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTICOAGULANTS; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; FEMALE; HUMANS; INCIDENCE; INTRA-AORTIC BALLOON PUMPING; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; POSTOPERATIVE HEMORRHAGE; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; TIME FACTORS; WHOLE BLOOD COAGULATION TIME;

EID: 62849107586     PISSN: 15538389     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carrev.2008.08.001     Document Type: Article

References (22)

1. Heer T., Zeymer U., Juenger C., Gitt A.K., Wienbergen H., Zahn R., Gottwik M., and Senges J. Beneficial effects of abciximab in patients with primary percutaneous intervention for acute ST segment elevation myocardial infarction in clinical practice. Heart 92 10 (2006) 1484-1489
2. Manoukian S.V., Feit F., Mehran R., Voeltz M.D., Ebrahimi R., Hamon M., Dangas G.D., Lincoff A.M., White H.D., Moses J.W., King S.B., Ohman E.M., and Stone G.W. Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial. J Am Coll Cardiol 49 12 (2007) 1362-1368
3. Keeley E.C., Boura J.A., and Grines C.L. Comparison of primary and facilitated percutaneous coronary interventions for ST-elevation myocardial infarction: quantitative review of randomised trials. Lancet 367 9510 (2006) 579-588
4. Kastrati A., Mehilli J., Neumann F.J., Dotzer F., ten Berg J., Bollwein H., Graf I., Ibrahim M., Pache J., Seyfarth M., Schuhlen H., Dirschinger J., Berger P.B., Schomig A., and Intracoronary Stenting and Antithrombotic: Regimen Rapid Early Action for Coronary Treatment 2 (ISAR-REACT 2) Trial Investigators. Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial. JAMA 295 13 (2006) 1531-1538
5. Kinnaird T.D., Stabile E., Mintz G.S., Lee C.W., Canos D.A., Gevorkian N., Pinnow E.E., Pichard A.D., Kent K.M., Satler L.F., Weissman N.J., Lindsay J., and Fuchs S. Incidence, predictors and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions. Am J Cardiol 92 (2003) 930-935
6. Hillegass W.B., Brott B.C., Chapman G.D., Phillips H.R., Stack R.S., Tcheng J.E., and Califf R.M. Relationship between activated clotting time during percutaneous intervention and subsequent bleeding complications. Am Heart J 144 3 (2002) 501-507
7. Dauerman H.L., Andreou C., Perras M.A., Spinner J.S., Lessard D., and Weiner B.H. Predictors of bleeding complications after rescue coronary interventions. J Thromb Thrombolysis 10 1 (2000) 83-88
8. Stone G.W., Grines C.L., Cox D.A., Garcia E., Tcheng J.E., Griffin J.J., Guagliumi G., Stuckey T., Turco M., Carroll J.D., Rutherford B.D., Lansky A.J., and Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Investigators. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med 346 13 (2002) 957-966
9. Halkin A., Singh M., Nikolsky E., Grines C.L., Tcheng J.E., Garcia E., Cox D.A., Turco M., Stuckey T.D., Na Y., Lansky A.J., Gersh B.J., O'Neill W.W., Mehran R., and Stone G.W. Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score. J Am Coll Cardiol 45 9 (2005) 1397-1405
10. Rao A.K., Pratt C., Berke A., et al. Thrombolysis in myocardial infarction (TIMI) trial-Phase 1: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase. J Am Coll Cardiol 11 (1988) 1-11
11. Moscucci M., Fox K.A., Cannon C.P., Klein W., López-Sendón J., Montalescot G., White K., and Goldberg R.J. Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE). Eur Heart J 24 (2003) 1815-1823
12. Yatskar L., Selzer F., Feit F., Cohen H.A., Jacobs A.K., Williams D.O., and Slater J. Access site hematoma requiring blood transfusion predicts mortality in patients undergoing percutaneous coronary intervention: Data from the National Heart, Lung, and Blood Institute Dynamic Registry. Catheter Cardiovasc Interv 69 7 (2007) 961-966
13. Abbas A.E., Brodie B., Dixon S., Marsalese D., Brewington S., O'Neill W.W., Grines L.L., and Grines C.L. Incidence and prognostic impact of gastrointestinal bleeding after percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol 96 2 (2005) 173-176
14. Ikelboom J.W., Mehta S.R., Anand S.S., Xie C., Fox K.A., and Yusuf S. Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. Circulation 114 8 (2006) 774-782
15. Rao S.V., O'Grady K., Pieper K.S., Granger C.B., Newby L.K., Mahaffey K.W., Moliterno D.J., Lincoff A.M., Armstrong P.W., Van de Werf F., Califf R.M., and Harrington R.A. A comparison of the clinical impact of bleeding measured by two different classifications among patients with acute coronary syndromes. J Am Coll Cardiol 47 4 (2006) 809-816
16. Spencer F.A., Moscucci M., Granger C.B., Gore J.M., Goldberg R.J., Steg P.G., Goodman S.G., Budaj A., FitzGerald G., Fox K.A., and GRACE Investigators. Does comorbidity account for the excess mortality in patients with major bleeding in acute myocardial infarction?. Circulation 116 (2007) 2793-2801
17. Sabatine M.S., Morrow D.A., Giugliano R.P., Burton P.B., Murphy S.A., McCabe C.H., Gibson C.M., and Braunwald E. Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation 111 16 (2005) 2042-2049
18. Rao S.V., Jollis J.G., Harrington R.A., Granger C.B., Newby L.K., Armstrong P.W., Moliterno D.J., Lindblad L., Pieper K., Topol E.J., Stamler J.S., and Califf R.M. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA 292 13 (2004) 1555-1562
19. Wu W.C., Rathore S.S., Wang Y., Radford M.J., and Krumholz H.M. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med 345 17 (2001) 1230-1236
20. Lansky A.J., Pietras C., Costa R.A., Tsuchiya Y., Brodie B.R., Cox D.A., Aymong E.D., Stuckey T.D., Garcia E., Tcheng J.E., Mehran R., Negoita M., Fahy M., Cristea E., Turco M., Leon M.B., Grines C.L., and Stone G.W. Gender differences in outcomes after primary angioplasty versus primary stenting with and without abciximab for acute myocardial infarction: results of the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. Circulation 111 13 (2005) 1611-1618
21. Vonderheide R.H., Thadhani R., and Kuter D.J. Association of thrombocytopenia with the use of intra-aortic balloon pumps. Am J Med 105 (1998) 27-32
22. Mishra S., Chu W.W., Torguson R., Wolfram R., Deible R., Suddath W.O., Pichard A.D., Satler L.F., Kent K.M., and Waksman R. Role of prophylactic intra-aortic balloon pump in high-risk patients undergoing percutaneous coronary intervention. Am J Cardiol 98 5 (2006) 608-612